AGC Biologics in Bothell to produce new diabetes treatment

Posted 2023-02-01, Herald Net Headlines

The contract drug manufacturer paired with... read full story

Ask about this article

Answer for your question of the article will be displayed here ...

Related News

AGC Biologics to Commercial Manufacture Provention Bio Diabetes Therapy (AGC Biologics Inc)

Public Technologies 2023-01-24, 15:15

AGC Biologics Supports Commercial Production of Provention Bio’s New Type 1 Diabetes (T1D) Therapy, TZIELD™

The Galveston Daily News 2023-01-24, 15:07

AGC Biologics and BioConnection Partner to Offer new End to End Biopharmaceutical Drug Substance and Drug Product Development and Manufacturing Offering (AGC Biologics Inc)

Public Technologies 2024-05-22, 11:56

Related News

RoosterBio and AGC Biologics Announce Collaboration to Accelerate Manufacturing of Cell and Exosome Therapies

The Associated Press
2022-08-16, 16:41

AGC Biologics Expands Cell Therapy Suites at Longmont ATMP Campus (AGC Biologics Inc)

Public Technologies
2023-08-23, 12:53

Almac Pharma Services Supports Rapid Launch of Provention Bio, Inc.’s Treatment TZIELD™ (teplizumab-mzwv) (Almac Group Ltd)

Public Technologies
2022-12-13, 16:08

AGC Biologics Copenhagen named Børsen Gazelle company for 2022 (AGC Biologics Inc)

Public Technologies
2023-02-09, 09:14

AGC and MEDINET Strategic Partnership to Accelerate CGT CDMO Business in Japan (AGC Biologics Inc)

Public Technologies
2024-09-17, 02:04

AGC Biologics selects Cytiva to provide FlexFactory platforms in new biomanufacturing facility in Japan (AGC Biologics Inc)

Public Technologies
2024-04-25, 15:04

AGC Biologics Signs TCR-T Cell Services Agreement to Support Medigene’s New Cell Therapy Product (AGC Biologics Inc)

Public Technologies
2023-10-25, 03:58

Sanofi US enters into co-promotion agreement with Provention Bio, Inc. to launch teplizumab, an investigational disease-modifying therapy for type 1 diabetes

PR Newswire
2022-10-06, 12:24